Is Karolinska Development (STO:KDEV) Using Too Much Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much debt can sink a company. As with many other companies Karolinska Development AB (publ) (STO:KDEV) makes use of debt. But should shareholders be worried about its use of debt?

Advertisement

When Is Debt Dangerous?

Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. If things get really bad, the lenders can take control of the business. However, a more frequent (but still costly) occurrence is where a company must issue shares at bargain-basement prices, permanently diluting shareholders, just to shore up its balance sheet. Of course, debt can be an important tool in businesses, particularly capital heavy businesses. When we examine debt levels, we first consider both cash and debt levels, together.

View our latest analysis for Karolinska Development

How Much Debt Does Karolinska Development Carry?

As you can see below, at the end of March 2021, Karolinska Development had kr77.3m of debt, up from kr70.0m a year ago. Click the image for more detail. However, it does have kr101.6m in cash offsetting this, leading to net cash of kr24.3m.

debt-equity-history-analysis
OM:KDEV Debt to Equity History August 20th 2021

A Look At Karolinska Development's Liabilities

The latest balance sheet data shows that Karolinska Development had liabilities of kr11.1m due within a year, and liabilities of kr77.3m falling due after that. Offsetting these obligations, it had cash of kr101.6m as well as receivables valued at kr2.08m due within 12 months. So it actually has kr15.3m more liquid assets than total liabilities.

This state of affairs indicates that Karolinska Development's balance sheet looks quite solid, as its total liabilities are just about equal to its liquid assets. So it's very unlikely that the kr842.0m company is short on cash, but still worth keeping an eye on the balance sheet. Succinctly put, Karolinska Development boasts net cash, so it's fair to say it does not have a heavy debt load! The balance sheet is clearly the area to focus on when you are analysing debt. But it is Karolinska Development's earnings that will influence how the balance sheet holds up in the future. So if you're keen to discover more about its earnings, it might be worth checking out this graph of its long term earnings trend.

In the last year Karolinska Development had a loss before interest and tax, and actually shrunk its revenue by 39%, to kr2.2m. To be frank that doesn't bode well.

So How Risky Is Karolinska Development?

We have no doubt that loss making companies are, in general, riskier than profitable ones. And we do note that Karolinska Development had an earnings before interest and tax (EBIT) loss, over the last year. And over the same period it saw negative free cash outflow of kr5.7m and booked a kr106m accounting loss. With only kr24.3m on the balance sheet, it would appear that its going to need to raise capital again soon. Even though its balance sheet seems sufficiently liquid, debt always makes us a little nervous if a company doesn't produce free cash flow regularly. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately, every company can contain risks that exist outside of the balance sheet. For instance, we've identified 3 warning signs for Karolinska Development (1 is concerning) you should be aware of.

If, after all that, you're more interested in a fast growing company with a rock-solid balance sheet, then check out our list of net cash growth stocks without delay.

When trading Karolinska Development or any other investment, use the platform considered by many to be the Professional's Gateway to the Worlds Market, Interactive Brokers. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted


Valuation is complex, but we're here to simplify it.

Discover if KDventures might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

MI
mitchell_lawler
mitchell_lawler

A landmark settlement is meant to punish Meta (META). If the 1998 tobacco deal is any guide, it might protect it.

A landmark settlement is meant to punish Meta (META). If the 1998 tobacco deal is any guide, it might protect it. cover
87
ZO
zoe_vi5fn

Any moat with an opt-out clause for your competitors is just a fence around your own garden.

CO
connor_iwn1g

Worth looking at what previous legal action actually did to Meta rather than reaching for tobacco. The FTC's record five billion dollar privacy fine in 2019 was met with the stock rising, because it came in below fears and removed an open question. GDPR was designed to constrain large platforms and increased their share of the European ad market, because compliance cost fell hardest on small intermediaries. The FTC's antitrust case, the one that could genuinely have broken the company up, was decided in Meta's favour last November. The only thing that ever meaningfully hurt the business was Apple changing a tracking default, and Meta out-spent that too, while the ad-tech firms that could not afford to rebuild disappeared. The pattern is not that Meta survives regulation. It is that regulation keeps costing its smaller competitors more.

Andrew Legget

Great earnings season, but are the earnings real?

Great earnings season, but are the earnings real? cover
At first glance, this was the strongest earnings season in years. But when you look at where the growth actually came from, the story splits into two very different pictures.
10

About OM:KDV B

KDventures

A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.

Flawless balance sheet with slight risk.

Advertisement

Weekly Picks

LO
Lou_Basenese
ONCY logo
Lou_Basenese on Oncolytics Biotech ·

The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech

Fair Value:US$3.575.7% undervalued
22 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
TR
tripledub
Recommended Voice
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$5862.5% undervalued
58 users have followed this narrative
3 users have commented on this narrative
34 users have liked this narrative
TA
Talos
Emerging Author
VOYG logo
Talos on Voyager Technologies ·

The "Landlord of Orbit" – A Deep Value Play Ahead of the Starlab Era

Fair Value:US$385.291.0% undervalued
56 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
IV
Emerging Author
UBER logo
Ivoed on Uber Technologies ·

Uber’s Valuation Depends On Who Captures The Economics Of Driverless Rides

Fair Value:US$11633.7% undervalued
12 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

LI
PEP logo
Lijo on PepsiCo ·

A classic growth and income compounder

Fair Value:US$116.4720.0% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RO
RockeTeller
BPAG logo
RockeTeller on BP Silver ·

BP Silver: 1,655 g/t Silver Hit + Phase 2 Underway, Is This $82M Market Cap the Next Bolivian Monster?

Fair Value:CA$132.8499.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TH
TheFutureOfValue
GQG logo
TheFutureOfValue on GQG Partners ·

Structural Resilience and Alpha Architecture: Why GQG Partners Represents an ASX Blue Chip Stock of the Future

Fair Value:AU$5.2474.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28018.6% undervalued
365 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9120.3% overvalued
213 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0946.1% undervalued
237 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative

Trending Discussion

AL
BUSER logo
AlfredB on Bambuser ·

Very Intresting Times for Bambuser

1
|
0
TT
6831 logo
TThe on Green Tea Group ·

Green tea dropped so much today

0
|
0
TE
HALO logo
Teg on Halozyme Therapeutics ·

You left out SnapShot.

0
|
0